Category Archives: Cardiovascular

Prevention of heart failure, tachyarrhythmias and sudden cardiac death in HIV

2022

PURPOSE OF REVIEW: To summarize the state-of-the-art literature on the epidemiology, disease progression, and mediators of heart failure, tachyarrhythmias, and sudden cardiac death in people living with HIV (PLWH) to...

Addressing gaps in cardiovascular care for people with HIV: Bridging scientific evidence and practice

2022

PURPOSE OF REVIEW: People with HIV continue to have an excess burden of cardiovascular disease compared to the general population. The reasons for these disparities in cardiovascular disease include HIV-specific...

Performance of cardiovascular risk prediction models among people living with HIV: A systematic review and meta-analysis

2023

Importance  Extant data on the performance of cardiovascular disease (CVD) risk score models in people living with HIV have not been synthesized. Objective  To synthesize available data on the performance of the...

Cardiovascular disease risk in women living with HIV

2022

PURPOSE OF REVIEW: To synthesize current evidence on the impact of cardiovascular disease among women living with HIV (WLWH) with a particular focus on disease prevalence, mechanisms and prevention. RECENT...

Risk of myocardial infarction in HIV patients: A systematic review

2022

Human immunodeficiency virus (HIV) is a retrovirus that is associated with mortality in the final stage. The advancement of antiretroviral therapy (ART) improved the life expectancy of patients with HIV....

Role of statin in reducing cardiovascular diseases in human immunodeficiency virus (HIV) patients: A systematic review

2022

Because of abnormal lipid profiles, the risk of patients living with human immunodeficiency virus (PLHIV) developing cardiovascular diseases (CVDs) is much greater than in the general population. Statins are known...

Statins for primary cardiovascular disease prevention among people with HIV: Emergent directions

2022

PURPOSE OF REVIEW: While people with HIV (PWH) are living longer due to advances in antiretroviral therapy, recent data have demonstrated an increased risk of cardiovascular disease (CVD) among this...

Multimorbidity of communicable and non-communicable diseases in low- and middle-income countries: A systematic review

2022

OBJECTIVE: The aim of this systematic review is to analyse existing evidence on prevalence, patterns, determinants, and healthcare challenges of communicable and non-communicable disease multimorbidity in low- and middle-income countries...

Factors influencing treatment adherence in hypertension and HIV management in South Africa: A comparative literature review

2022

BACKGROUND: Hypertension (HTN) is the most significant risk factor for cardiovascular disease (CVD) in South Africa (SA), with one in three people over the age of 25 suffering from HTN....

Association of HIV infection with cardiovascular pathology based on advanced cardiovascular imaging: A systematic review

2022

Importance: HIV-associated cardiovascular disease is increasing in prevalence, but its mechanisms remain poorly understood. Objective: To systematically review data from advanced cardiovascular imaging studies evaluating computed tomographic coronary angiography, positron emission tomography...

A Systematic review exploring the effect of human immunodeficiency virus on cardiac diseases

2022

Human immunodeficiency virus (HIV) primarily affects the immune systems, which, if progressed, will lead to acquired immunodeficiency syndrome (AIDS). Currently, there is no effective cure for the disease, and patients...

Incidence and risk factors of atrial fibrillation and atrial arrhythmias in people living with HIV: A systematic review and meta-analysis

2022

BACKGROUND: Cardiovascular diseases in people living with HIV (PLWH) are becoming increasingly relevant as HIV/AIDS has become more treatable with the advent of highly efficacious antiretroviral therapy. Previous studies suggested...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!